Unlock instant, AI-driven research and patent intelligence for your innovation.

Monoclonal antibody of glycosylphosphatidylinositol-anchored proteins (C4.4A) and application of monoclonal antibody

A technology of glycosylphosphatidylinositol and glycoprotein, which is applied in the field of biomedicine and can solve problems such as the lack of antibody tools

Active Publication Date: 2020-06-30
艾比玛特医药科技(上海)有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Lack of effective antibody tools for this research area

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody of glycosylphosphatidylinositol-anchored proteins (C4.4A) and application of monoclonal antibody
  • Monoclonal antibody of glycosylphosphatidylinositol-anchored proteins (C4.4A) and application of monoclonal antibody
  • Monoclonal antibody of glycosylphosphatidylinositol-anchored proteins (C4.4A) and application of monoclonal antibody

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0128] Preparation of monoclonal antibodies

[0129]Antibodies of the present invention can be prepared by various techniques known to those skilled in the art. For example, an antigen of the invention may be administered to an animal to induce the production of monoclonal antibodies. For monoclonal antibodies, hybridoma technology can be used to prepare (see Kohler et al., Nature 256; 495, 1975; Kohler et al., Eur.J.Immunol.6:511, 1976; Kohler et al., Eur.J.Immunol. 6:292,1976; Hammerling et al., In Monoclonal Antibodies and T Cell Hybridomas, Elsevier, N.Y., 1981) or can be prepared by recombinant DNA methods (US Patent No. 4,816,567).

[0130] Representative myeloma cells are those that fuse efficiently, support stable high-level production of antibody by selected antibody-producing cells, and are sensitive to culture medium (HAT medium matrix), including myeloma cell lines, such as murine Myeloma cell lines, including those derived from MOPC-21 and MPC-11 mouse tumors (a...

Embodiment 1

[0150] Example 1 Elisa (immunoenzyme-linked) pairing verification of antibody and antigenic polypeptide

[0151] Coat the 96-well ELISA plate with ascites antibody to be paired, incubate, wash and block overnight with skim milk, wash with PBS, and store at 4°C until use. Antigen peptides were incubated, washed with PBS, and controls were set at the same time. HRP-labeled detection antibody was added to the previously incubated ELISA plate. TMB color reaction, microplate reader reading. The titers of the 8 cell lines obtained by screening are shown in Table 2:

[0152] Table 2 Titers of 8 cell lines

[0153] Antibody name clone number 3.125K 6.25K 12.5K 25K 50K 100K 200K 400K 800K 1600K PC NC whether it is passed potency anti-C4.4A 2A1 2.866 2.791 2.73 2.566 1.846 1.284 0.682 0.304 0.121 0.064 3.016 0.238 qualified 400K Anti-C4.5A 3B6 2.652 2.641 2.243 1.561 1.084 0.583 0.339 0.152 0.081 0.04 3.188 0.151 ...

Embodiment 2

[0154] Example 2 Flow Cytometry Verification of Antibodies

[0155] PC9 cells were washed with PBS, digested with EDTA, transferred to a centrifuge tube, centrifuged to discard the supernatant and resuspended with PBS, blocked with goat serum at room temperature for 1 hour, incubated with primary antibody, working concentration 50ug / ml, incubated with fluorescent secondary antibody, working concentration 1 : 300. result( figure 2 ) shows that this antibody can be applied to the flow cytometry experiment of C4.4A.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a monoclonal antibody of glycosylphosphatidylinositol-anchored proteins (C4.4A) and an application of the monoclonal antibody. Experimental results show that the antibody can beapplied to antibody chip reaction, immunoprecipitation, Western Blotting, flow cytometry and living cell enrichment for protein research.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular, the invention relates to a monoclonal antibody of glycosylphosphatidylinositol-anchored glycoprotein (C4.4A) and application thereof. Background technique [0002] C4.4A is a glycosylphosphatidyl muscle-anchored glycoprotein with 346 amino acid residues, which belongs to the Ly-6 family member. Studies have shown that C4.4A mRNA is rarely expressed in normal tissues, only highly expressed in placenta and skin tissues, and weakly expressed in esophagus and bladder. However, experiments have shown that the expression of C4.4A mRNA is up-regulated in malignant melanoma, lung cancer, breast cancer and bladder cancer, and its expression intensity is higher in metastatic tissues. Therefore, it is speculated that C4.4A may be related to tumor invasion and metastasis. At present, most tumor metastasis cannot be diagnosed early. Although some immune-related molecules play a good role in the diag...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/30C12N15/13C12N5/10G01N33/574
CPCC07K16/3046G01N33/57446G01N33/57484C07K2317/35C12N2510/00
Inventor 翁炜宁张喆孟逊
Owner 艾比玛特医药科技(上海)有限公司